Author Archive | MANCEF.org

Biotherapeutics

Biotherapeutics device attracts $7m investment

A Cambridge life sciences company that has developed a revolutionary system for single-cell analysis in the biopharmaceutical market, with support from Innovate UK, has secured private investment totalling $7 million. Sphere Fluidics Ltd’s Cyto-Mine® device promises to transform the discovery and development of biotherapeutics for treatment of cancer and inflammatory diseases and vaccine generation. The […]

Continue Reading
MAM 2015

Report on MAM2015

Final Remarks MAM 2015 by Volker Saile. MANCEF was pleased once again to partner with Micronarc to have organized the 6th MAM workshop in Switzerland. MAM 2015 was held on February 1-3 at Villars-sur-Ollon.

Continue Reading